Takeda Pharmaceutical (Respiratory Business) Overview
- Status
-
Acquired/Merged
- Employees
-
200
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Takeda Pharmaceutical (Respiratory Business) General Information
Description
Developer of pharmaceutical for respiratory treatments. The company develops and distributes respiratory medicines and early pipeline products. It also supplies respiratory products, including Alvesco and Omnaris, a steroid that reduces inflammation.
Contact Information
Corporate Office
- 4-1-1 Dosho-machi
- Chuo-ku Osaka City
- Osaka, 540-8645
- Japan
Corporate Office
- 4-1-1 Dosho-machi
- Chuo-ku Osaka City
- Osaka, 540-8645
- Japan
Takeda Pharmaceutical (Respiratory Business) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Takeda Pharmaceutical (Respiratory Business) Signals
Takeda Pharmaceutical (Respiratory Business) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Takeda Pharmaceutical (Respiratory Business) FAQs
-
Where is Takeda Pharmaceutical (Respiratory Business) headquartered?
Takeda Pharmaceutical (Respiratory Business) is headquartered in Osaka, Japan.
-
What is the size of Takeda Pharmaceutical (Respiratory Business)?
Takeda Pharmaceutical (Respiratory Business) has 200 total employees.
-
What industry is Takeda Pharmaceutical (Respiratory Business) in?
Takeda Pharmaceutical (Respiratory Business)’s primary industry is Pharmaceuticals.
-
Is Takeda Pharmaceutical (Respiratory Business) a private or public company?
Takeda Pharmaceutical (Respiratory Business) is a Private company.
-
What is the current valuation of Takeda Pharmaceutical (Respiratory Business)?
The current valuation of Takeda Pharmaceutical (Respiratory Business) is 00000.
-
What is Takeda Pharmaceutical (Respiratory Business)’s current revenue?
The current revenue for Takeda Pharmaceutical (Respiratory Business) is 000000.
-
Who are Takeda Pharmaceutical (Respiratory Business)’s investors?
Takeda Pharmaceutical Company has invested in Takeda Pharmaceutical (Respiratory Business).
-
When was Takeda Pharmaceutical (Respiratory Business) acquired?
Takeda Pharmaceutical (Respiratory Business) was acquired on 01-Mar-2016.
-
Who acquired Takeda Pharmaceutical (Respiratory Business)?
Takeda Pharmaceutical (Respiratory Business) was acquired by AstraZeneca.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »